Lapix Therapeutics Inc.
through Aug 5, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Feb 10, 2025 · D/A | Aug 5, 2025 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $6,000,000 | $5,000,000 | $-1,000,000 |
| Reported amount sold | $5,520,946 | $2,200,000 | $-3,320,946 |
| Reported investor count | — | — | — |
| Reported minimum investment | $0 | $1,000 | $1,000 |
Earlier SEC source: 0001947620-25-000001 · Later SEC source: 0001947620-25-000003
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $5,000,000
- Reported amount sold
- $2,200,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0001947620-25-000003D · Aug 5, 2025 · Other TechnologyOffering: $5,000,000Sold: $2,200,000
-
0001947620-25-000001D/A · Feb 10, 2025 · BiotechnologyOffering: $6,000,000Sold: $5,520,946